Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
25.70
+0.46 (1.82%)
At close: Nov 3, 2026, 4:00 PM EST
25.49
-0.21 (-0.82%)
After-hours: Nov 3, 2026, 7:59 PM EST
Hims & Hers Health Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Hims & Hers Health stock has a consensus rating of "Hold" and an average price target of $31.15. The average 1-year stock price forecast is 21.21% higher than the current stock price, while the lowest is $23 (-10.51%) and the highest is $42 (+63.42%).
Price Target: $31.15 (+21.21%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Hims & Hers Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Hold | 12 | 11 | 12 | 11 | 11 | 12 |
| Sell | 0 | 1 | 0 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 15 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $35 | Buy | Maintains | $35 | +36.19% | Oct 29, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $32 | Hold | Maintains | $32 | +24.51% | Oct 29, 2026 |
| Truist Financial | Truist Financial | Hold Reiterates $32 | Hold | Reiterates | $32 | +24.51% | Sep 11, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Initiates $32 | Hold | Initiates | $32 | +24.51% | Sep 11, 2026 |
| Jefferies | Jefferies | Hold Maintains $31 | Hold | Maintains | $31 | +20.62% | Sep 3, 2026 |
Financial Forecast
Revenue This Year
3.21B
from 2.35B
Increased by 36.65%
Revenue Next Year
4.00B
from 3.21B
Increased by 24.59%
EPS This Year
0.28
from 1.10
Decreased by -74.36%
EPS Next Year
0.74
from 0.28
Increased by 161.00%
EPS and Forward PE are based on non-GAAP adjusted numbers.